Hyseq obtains patent rights for gene technology:
This article was originally published in Clinica
Hyseq has patented a gene sequence-assembling technology which allows researchers to investigate gene-related diseases, such as cancer and cardiovascular and infectious diseases, with greater speed and efficiency. The method is an automated technique for handling long sequences of genetic material, reducing the ambiguity of the current SBH technology. The US company is investigating a number of genes to determine their suitability for development into diagnostic and pharmaceutical products (see article on p 10).
You may also be interested in...
After urging the US Congress to act on updating Medicare Part D, the Association for Accessible Medicines has welcomed the decision to update Part D by the Centers for Medicare & Medicaid Services of the US Department of Health and Human Services.
Dr Reddy’s signals a sharp step up in ambitions at home, propelled by building leadership in 10 therapy segments and an “India-first” approach for specialty products. Uptick in the China business and the potential launch of a Russia-partnered COVID-19 vaccine were other aspects of the business discussed at JPM.
“You can’t just live off the brand equity anymore,” warned J&J's Consumer Health's Minoj Raghunandanan during the ‘Advancing Trust in the Self-Care Industry’ webinar co-hosted by the Global Self-Care Federation and HBW Insight. “You’ve got to continue to build that trust between consumers and products day-in day-out.”